Keyphrases
Neuroprotective Effect
100%
Retinal Ganglion Cells
100%
C-Jun
100%
Kinase Inhibitor
100%
C-Jun N-terminal Kinase
100%
SP600125
100%
Retina
71%
Ischemia-reperfusion Injury
57%
Jun N-terminal Kinase Inhibitor
57%
Superior Colliculus
42%
C-Jun N-terminal Kinase Signaling
42%
Phosphorylation
28%
Retinal Ganglion Cell Death
28%
Ganglion Cell-inner Plexiform Layer (GC-IPL)
28%
Retinal Layers
28%
Electroretinography
28%
Cell number
28%
Scotopic
28%
Retinal Ischemia
28%
Retinal Cells
28%
Therapeutic Strategies
14%
Reperfusion
14%
Intraocular Pressure
14%
Protective Effect
14%
Neuroprotection
14%
Inner Plexiform Layer
14%
Spectral Domain Optical Coherence Tomography (SD-OCT)
14%
C57BL
14%
Pathophysiology
14%
Immunohistochemistry
14%
Morphological Changes
14%
Retinal Degeneration
14%
In Vivo Model
14%
Once-daily
14%
Synaptic Markers
14%
Inner nuclear Layer
14%
Adult Rats
14%
Visual Axis
14%
Retinal Function
14%
Immunoblotting
14%
Rat Retinal Ganglion Cells
14%
B-wave
14%
Wave Amplitude
14%
Ischemia-reperfusion Model
14%
Volumetric Measurement
14%
Induced Loss
14%
Glucose Transporter 2 (GLUT2)
14%
Glutamate Excitotoxicity
14%
Postsynaptic Density Protein 95 (PSD-95)
14%
In Vitro Effect
14%
Trophic Factors
14%
Medicine and Dentistry
Ganglion
100%
Neuroprotective Agent
100%
Phosphotransferase Inhibitor
100%
Amino Terminal Sequence
100%
In Vitro
100%
anthra[1,9 Cd]pyrazol 6(2h) One
63%
Phosphotransferase
45%
Ischemia
36%
Superior Colliculus
27%
Injury
18%
Cell Death
18%
Electroretinography
18%
Dark Adaptation
18%
Ganglion Cell Layer
18%
Retina Ischemia
18%
Reperfusion Injury
18%
Signal Transduction
9%
Inner Plexiform Layer
9%
Spectral Domain Optical Coherence Tomography
9%
Morphology
9%
Intraocular Pressure
9%
Neuroprotection
9%
Pathophysiology
9%
Immunoblotting
9%
Vesicular Glutamate Transporter 2
9%
Glutamate Excitotoxicity
9%
Inner Nuclear Layer
9%
Immunohistochemistry
9%
Kinase Signaling
9%
Flushing
9%
Retina Degeneration
9%
Trophic Factor
9%
Neuroscience
Retinal Ganglion Cell
100%
In Vivo
100%
In Vitro
100%
Neuroprotective Agent
100%
Kinase
100%
Amino Terminal Sequence
100%
Ischemia
45%
Superior Colliculus
27%
Electroretinography
18%
Cell Death
18%
Ganglion Cell
18%
Reperfusion Injury
18%
Intraocular Pressure
9%
Neuroprotection
9%
Cell Signaling
9%
Immunohistochemistry
9%
Glutamic Acid
9%
Excitotoxicity
9%
Retinal Degeneration
9%
Vesicular Glutamate Transporter 2
9%
Immunoblotting
9%